Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin kappa variable 1-8 (IGKV1-8)
- Target
- IGKV1-8
- Molecular classification
- Other (Immunoglobulin variable region gene)
01
Overview
Immunoglobulin kappa variable 1-8 (IGKV1-8) is a gene that encodes the variable region of the light chain of immunoglobulin (antibody) molecules in humans. This gene segment contributes to the antigen-binding domain of immunoglobulins, enabling immune recognition of diverse pathogens. It is not a therapeutic target itself, but it is vital for antibody diversity through somatic recombination and affinity maturation in B cells. IGKV1-8 is expressed as part of normal and disease-associated immunoglobulin repertoires, where it may be involved in immune response and antigen recognition, but it is not targeted by drugs or used as a biomarker in isolation[1][2][4][5][6][10].
- Other names
- Immunoglobulin kappa variable 1-8IGKV1-8IGKV18L9KV108
02
Mechanism of action
Not applicable (as a genetic segment of antibody variable regions, it is not directly druggable)
03
Biological functions
Antigen bindingImmune response
04
Disease associations
Other (as component of immunoglobulin repertoire in immune and autoimmune diseases, not a primary or direct disease target)
05
Safety considerations
None specific (not a therapeutic target; therefore, safety issues do not directly apply)
06
Interacting drugs
None (no direct drugs target IGKV1-8 itself; drugs target the antibody or B cell as a whole)
07
Biomarkers
None specific (no indication that IGKV1-8 alone is used as a biomarker)
Beyond the preview
Go deeper on Immunoglobulin kappa variable 1-8 (IGKV1-8).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin kappa variable 1-8 (IGKV1-8).